Identification of a competing endogenous RNA network associated with prognosis of pancreatic adenocarcinoma

Background Emerging evidence suggests that competing endogenous RNAs plays a crucial role in the development and progress of pancreatic adenocarcinoma (PAAD). The objective was to identify a new lncRNA-miRNA-mRNA network as prognostic markers, and develop and validate a multi-mRNAs-based classifier...

Full description

Saved in:
Bibliographic Details
Published inCancer cell international Vol. 20; no. 1; pp. 231 - 14
Main Authors Weng, Wanqing, Zhang, Zhongjing, Huang, Weiguo, Xu, Xiangxiang, Wu, Boda, Ye, Tingbo, Shan, Yunfeng, Shi, Keqing, Lin, Zhuo
Format Journal Article
LanguageEnglish
Published London BioMed Central 11.06.2020
BMC
Subjects
Online AccessGet full text
ISSN1475-2867
1475-2867
DOI10.1186/s12935-020-01243-6

Cover

Abstract Background Emerging evidence suggests that competing endogenous RNAs plays a crucial role in the development and progress of pancreatic adenocarcinoma (PAAD). The objective was to identify a new lncRNA-miRNA-mRNA network as prognostic markers, and develop and validate a multi-mRNAs-based classifier for predicting overall survival (OS) in PAAD. Methods Data on pancreatic RNA expression and clinical information of 445 PAAD patients and 328 normal subjects were downloaded from The Cancer Genome Atlas (TCGA), International Cancer Genome Consortium (ICGC) and Genotype-Tissue Expression (GTEx). The weighted correlation network analysis (WGCNA) was used to analyze long non-coding RNA (lncRNA) and mRNA, clustering genes with similar expression patterns. MiRcode was used to predict the sponge microRNAs (miRNAs) corresponding to lncRNAs. The downstream targeted mRNAs of miRNAs were identified by starBase, miRDB, miRTarBase and Targetscan. A multi-mRNAs-based classifier was develop using least absolute shrinkage and selection operator method (LASSO) COX regression model, which was tested in an independent validation cohort. Results A lncRNA-miRNA-mRNA co-expression network which consisted of 60 lncRNAs, 3 miRNAs and 3 mRNAs associated with the prognosis of patients with PAAD was established. In addition, we constructed a 14-mRNAs-based classifier based on a training cohort composed of 178 PAAD patients, of which the area under receiver operating characteristic (AUC) in predicting 1-year, 3-year, and 5-year OS was 0.719, 0.806 and 0.794, respectively. The classifier also shown good prediction function in independent verification cohorts, with the AUC of 0.604, 0.639 and 0.607, respectively. Conclusions A novel competitive endogenous RNA (ceRNA) network associated with progression of PAAD could be used as a reference for future molecular biology research.
AbstractList Background Emerging evidence suggests that competing endogenous RNAs plays a crucial role in the development and progress of pancreatic adenocarcinoma (PAAD). The objective was to identify a new lncRNA-miRNA-mRNA network as prognostic markers, and develop and validate a multi-mRNAs-based classifier for predicting overall survival (OS) in PAAD. Methods Data on pancreatic RNA expression and clinical information of 445 PAAD patients and 328 normal subjects were downloaded from The Cancer Genome Atlas (TCGA), International Cancer Genome Consortium (ICGC) and Genotype-Tissue Expression (GTEx). The weighted correlation network analysis (WGCNA) was used to analyze long non-coding RNA (lncRNA) and mRNA, clustering genes with similar expression patterns. MiRcode was used to predict the sponge microRNAs (miRNAs) corresponding to lncRNAs. The downstream targeted mRNAs of miRNAs were identified by starBase, miRDB, miRTarBase and Targetscan. A multi-mRNAs-based classifier was develop using least absolute shrinkage and selection operator method (LASSO) COX regression model, which was tested in an independent validation cohort. Results A lncRNA-miRNA-mRNA co-expression network which consisted of 60 lncRNAs, 3 miRNAs and 3 mRNAs associated with the prognosis of patients with PAAD was established. In addition, we constructed a 14-mRNAs-based classifier based on a training cohort composed of 178 PAAD patients, of which the area under receiver operating characteristic (AUC) in predicting 1-year, 3-year, and 5-year OS was 0.719, 0.806 and 0.794, respectively. The classifier also shown good prediction function in independent verification cohorts, with the AUC of 0.604, 0.639 and 0.607, respectively. Conclusions A novel competitive endogenous RNA (ceRNA) network associated with progression of PAAD could be used as a reference for future molecular biology research.
Emerging evidence suggests that competing endogenous RNAs plays a crucial role in the development and progress of pancreatic adenocarcinoma (PAAD). The objective was to identify a new lncRNA-miRNA-mRNA network as prognostic markers, and develop and validate a multi-mRNAs-based classifier for predicting overall survival (OS) in PAAD. Data on pancreatic RNA expression and clinical information of 445 PAAD patients and 328 normal subjects were downloaded from The Cancer Genome Atlas (TCGA), International Cancer Genome Consortium (ICGC) and Genotype-Tissue Expression (GTEx). The weighted correlation network analysis (WGCNA) was used to analyze long non-coding RNA (lncRNA) and mRNA, clustering genes with similar expression patterns. MiRcode was used to predict the sponge microRNAs (miRNAs) corresponding to lncRNAs. The downstream targeted mRNAs of miRNAs were identified by starBase, miRDB, miRTarBase and Targetscan. A multi-mRNAs-based classifier was develop using least absolute shrinkage and selection operator method (LASSO) COX regression model, which was tested in an independent validation cohort. A lncRNA-miRNA-mRNA co-expression network which consisted of 60 lncRNAs, 3 miRNAs and 3 mRNAs associated with the prognosis of patients with PAAD was established. In addition, we constructed a 14-mRNAs-based classifier based on a training cohort composed of 178 PAAD patients, of which the area under receiver operating characteristic (AUC) in predicting 1-year, 3-year, and 5-year OS was 0.719, 0.806 and 0.794, respectively. The classifier also shown good prediction function in independent verification cohorts, with the AUC of 0.604, 0.639 and 0.607, respectively. A novel competitive endogenous RNA (ceRNA) network associated with progression of PAAD could be used as a reference for future molecular biology research.
Background Emerging evidence suggests that competing endogenous RNAs plays a crucial role in the development and progress of pancreatic adenocarcinoma (PAAD). The objective was to identify a new lncRNA-miRNA-mRNA network as prognostic markers, and develop and validate a multi-mRNAs-based classifier for predicting overall survival (OS) in PAAD. Methods Data on pancreatic RNA expression and clinical information of 445 PAAD patients and 328 normal subjects were downloaded from The Cancer Genome Atlas (TCGA), International Cancer Genome Consortium (ICGC) and Genotype-Tissue Expression (GTEx). The weighted correlation network analysis (WGCNA) was used to analyze long non-coding RNA (lncRNA) and mRNA, clustering genes with similar expression patterns. MiRcode was used to predict the sponge microRNAs (miRNAs) corresponding to lncRNAs. The downstream targeted mRNAs of miRNAs were identified by starBase, miRDB, miRTarBase and Targetscan. A multi-mRNAs-based classifier was develop using least absolute shrinkage and selection operator method (LASSO) COX regression model, which was tested in an independent validation cohort. Results A lncRNA-miRNA-mRNA co-expression network which consisted of 60 lncRNAs, 3 miRNAs and 3 mRNAs associated with the prognosis of patients with PAAD was established. In addition, we constructed a 14-mRNAs-based classifier based on a training cohort composed of 178 PAAD patients, of which the area under receiver operating characteristic (AUC) in predicting 1-year, 3-year, and 5-year OS was 0.719, 0.806 and 0.794, respectively. The classifier also shown good prediction function in independent verification cohorts, with the AUC of 0.604, 0.639 and 0.607, respectively. Conclusions A novel competitive endogenous RNA (ceRNA) network associated with progression of PAAD could be used as a reference for future molecular biology research.
Emerging evidence suggests that competing endogenous RNAs plays a crucial role in the development and progress of pancreatic adenocarcinoma (PAAD). The objective was to identify a new lncRNA-miRNA-mRNA network as prognostic markers, and develop and validate a multi-mRNAs-based classifier for predicting overall survival (OS) in PAAD.BACKGROUNDEmerging evidence suggests that competing endogenous RNAs plays a crucial role in the development and progress of pancreatic adenocarcinoma (PAAD). The objective was to identify a new lncRNA-miRNA-mRNA network as prognostic markers, and develop and validate a multi-mRNAs-based classifier for predicting overall survival (OS) in PAAD.Data on pancreatic RNA expression and clinical information of 445 PAAD patients and 328 normal subjects were downloaded from The Cancer Genome Atlas (TCGA), International Cancer Genome Consortium (ICGC) and Genotype-Tissue Expression (GTEx). The weighted correlation network analysis (WGCNA) was used to analyze long non-coding RNA (lncRNA) and mRNA, clustering genes with similar expression patterns. MiRcode was used to predict the sponge microRNAs (miRNAs) corresponding to lncRNAs. The downstream targeted mRNAs of miRNAs were identified by starBase, miRDB, miRTarBase and Targetscan. A multi-mRNAs-based classifier was develop using least absolute shrinkage and selection operator method (LASSO) COX regression model, which was tested in an independent validation cohort.METHODSData on pancreatic RNA expression and clinical information of 445 PAAD patients and 328 normal subjects were downloaded from The Cancer Genome Atlas (TCGA), International Cancer Genome Consortium (ICGC) and Genotype-Tissue Expression (GTEx). The weighted correlation network analysis (WGCNA) was used to analyze long non-coding RNA (lncRNA) and mRNA, clustering genes with similar expression patterns. MiRcode was used to predict the sponge microRNAs (miRNAs) corresponding to lncRNAs. The downstream targeted mRNAs of miRNAs were identified by starBase, miRDB, miRTarBase and Targetscan. A multi-mRNAs-based classifier was develop using least absolute shrinkage and selection operator method (LASSO) COX regression model, which was tested in an independent validation cohort.A lncRNA-miRNA-mRNA co-expression network which consisted of 60 lncRNAs, 3 miRNAs and 3 mRNAs associated with the prognosis of patients with PAAD was established. In addition, we constructed a 14-mRNAs-based classifier based on a training cohort composed of 178 PAAD patients, of which the area under receiver operating characteristic (AUC) in predicting 1-year, 3-year, and 5-year OS was 0.719, 0.806 and 0.794, respectively. The classifier also shown good prediction function in independent verification cohorts, with the AUC of 0.604, 0.639 and 0.607, respectively.RESULTSA lncRNA-miRNA-mRNA co-expression network which consisted of 60 lncRNAs, 3 miRNAs and 3 mRNAs associated with the prognosis of patients with PAAD was established. In addition, we constructed a 14-mRNAs-based classifier based on a training cohort composed of 178 PAAD patients, of which the area under receiver operating characteristic (AUC) in predicting 1-year, 3-year, and 5-year OS was 0.719, 0.806 and 0.794, respectively. The classifier also shown good prediction function in independent verification cohorts, with the AUC of 0.604, 0.639 and 0.607, respectively.A novel competitive endogenous RNA (ceRNA) network associated with progression of PAAD could be used as a reference for future molecular biology research.CONCLUSIONSA novel competitive endogenous RNA (ceRNA) network associated with progression of PAAD could be used as a reference for future molecular biology research.
Abstract Background Emerging evidence suggests that competing endogenous RNAs plays a crucial role in the development and progress of pancreatic adenocarcinoma (PAAD). The objective was to identify a new lncRNA-miRNA-mRNA network as prognostic markers, and develop and validate a multi-mRNAs-based classifier for predicting overall survival (OS) in PAAD. Methods Data on pancreatic RNA expression and clinical information of 445 PAAD patients and 328 normal subjects were downloaded from The Cancer Genome Atlas (TCGA), International Cancer Genome Consortium (ICGC) and Genotype-Tissue Expression (GTEx). The weighted correlation network analysis (WGCNA) was used to analyze long non-coding RNA (lncRNA) and mRNA, clustering genes with similar expression patterns. MiRcode was used to predict the sponge microRNAs (miRNAs) corresponding to lncRNAs. The downstream targeted mRNAs of miRNAs were identified by starBase, miRDB, miRTarBase and Targetscan. A multi-mRNAs-based classifier was develop using least absolute shrinkage and selection operator method (LASSO) COX regression model, which was tested in an independent validation cohort. Results A lncRNA-miRNA-mRNA co-expression network which consisted of 60 lncRNAs, 3 miRNAs and 3 mRNAs associated with the prognosis of patients with PAAD was established. In addition, we constructed a 14-mRNAs-based classifier based on a training cohort composed of 178 PAAD patients, of which the area under receiver operating characteristic (AUC) in predicting 1-year, 3-year, and 5-year OS was 0.719, 0.806 and 0.794, respectively. The classifier also shown good prediction function in independent verification cohorts, with the AUC of 0.604, 0.639 and 0.607, respectively. Conclusions A novel competitive endogenous RNA (ceRNA) network associated with progression of PAAD could be used as a reference for future molecular biology research.
ArticleNumber 231
Author Shan, Yunfeng
Lin, Zhuo
Weng, Wanqing
Zhang, Zhongjing
Wu, Boda
Shi, Keqing
Xu, Xiangxiang
Huang, Weiguo
Ye, Tingbo
Author_xml – sequence: 1
  givenname: Wanqing
  surname: Weng
  fullname: Weng, Wanqing
  organization: Zhejiang Provincial Key Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Precision Medicine Center Laboratory, The First Affiliated Hospital of Wenzhou Medical University
– sequence: 2
  givenname: Zhongjing
  surname: Zhang
  fullname: Zhang, Zhongjing
  organization: Zhejiang Provincial Key Laboratory, The First Affiliated Hospital of Wenzhou Medical University
– sequence: 3
  givenname: Weiguo
  surname: Huang
  fullname: Huang, Weiguo
  organization: Zhejiang Provincial Key Laboratory, The First Affiliated Hospital of Wenzhou Medical University
– sequence: 4
  givenname: Xiangxiang
  surname: Xu
  fullname: Xu, Xiangxiang
  organization: Zhejiang Provincial Key Laboratory, The First Affiliated Hospital of Wenzhou Medical University
– sequence: 5
  givenname: Boda
  surname: Wu
  fullname: Wu, Boda
  organization: Zhejiang Provincial Key Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Precision Medicine Center Laboratory, The First Affiliated Hospital of Wenzhou Medical University
– sequence: 6
  givenname: Tingbo
  surname: Ye
  fullname: Ye, Tingbo
  organization: Zhejiang Provincial Key Laboratory, The First Affiliated Hospital of Wenzhou Medical University
– sequence: 7
  givenname: Yunfeng
  surname: Shan
  fullname: Shan, Yunfeng
  email: shanyunfeng@wmu.edu.cn
  organization: Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University
– sequence: 8
  givenname: Keqing
  orcidid: 0000-0002-5070-3834
  surname: Shi
  fullname: Shi, Keqing
  email: skochilly@wmu.edu.cn
  organization: Zhejiang Provincial Key Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Precision Medicine Center Laboratory, The First Affiliated Hospital of Wenzhou Medical University
– sequence: 9
  givenname: Zhuo
  surname: Lin
  fullname: Lin, Zhuo
  email: biolinz@163.com
  organization: Department of Liver Diseases, The First Affiliated Hospital of Wenzhou Medical University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32536819$$D View this record in MEDLINE/PubMed
BookMark eNp9kktv1DAUhSNURB_wB1igSGzYBPyKHxukqqJlpAokBGvrxrFTTzN2sDOt-Pd4Ji20XXRjW_Y5n47vvcfVQYjBVtVbjD5iLPmnjImibYMIahAmjDb8RXWEmWgbIrk4eHA-rI5zXiOEheToVXVISUu5xOqoul71NszeeQOzj6GOrobaxM1kZx-G2oY-DjbEba5_fDutg51vY7quIedoPMy2r2_9fFVPKQ4hZp93_gmCSbbgTA0FHg0k40PcwOvqpYMx2zd3-0n16_zLz7OvzeX3i9XZ6WVjOMNz01FwVAguBEWsFZJK5Szj0pUVG8V7Bc50RgphZd-hVmAHhBgJPRVUtC09qVYLt4-w1lPyG0h_dASv9xcxDRpSiTda7VBPQSnbS0oZAO-EZQyUdQwZQjpeWJ8X1rTtNrY3pVgJxkfQxy_BX-kh3mhBZKk1LYAPd4AUf29tnvXGZ2PHEYItZdWEYaqUIhIX6fsn0nXcplBKtVMxKZUkpKjePUz0L8p9T4tALgKTYs7JOm38vO9uCehHjZHejY9exkeX8dH78dG735In1nv6sya6mHIRh8Gm_7Gfcf0Fm8nZNQ
CitedBy_id crossref_primary_10_18632_aging_202638
crossref_primary_10_3724_abbs_2022194
crossref_primary_10_1002_kjm2_12522
crossref_primary_10_1007_s13258_021_01185_x
crossref_primary_10_1615_CritRevEukaryotGeneExpr_2023048337
crossref_primary_10_1080_15476286_2021_1930755
crossref_primary_10_3389_fonc_2021_745166
crossref_primary_10_3390_genes15091139
crossref_primary_10_2147_CMAR_S287676
crossref_primary_10_3389_fonc_2021_765216
crossref_primary_10_1096_fj_202302475RRR
crossref_primary_10_1186_s12935_020_01381_x
crossref_primary_10_3389_fphar_2023_1091378
crossref_primary_10_1080_21655979_2021_1933868
crossref_primary_10_1155_2023_6785005
crossref_primary_10_1007_s10528_024_10750_4
crossref_primary_10_1097_MD_0000000000037322
crossref_primary_10_1038_s41598_021_90755_w
crossref_primary_10_3390_ijms22126295
crossref_primary_10_1038_s41598_022_13045_z
crossref_primary_10_1371_journal_pone_0252452
crossref_primary_10_1155_2021_6226291
crossref_primary_10_1016_j_heliyon_2024_e37715
crossref_primary_10_3389_pore_2021_587130
Cites_doi 10.3390/ijms20123079
10.1158/0008-5472.CAN-19-1116
10.18632/aging.101933
10.18632/aging.102140
10.3934/mbe.2019347
10.1097/MPA.0000000000001230
10.1016/j.sigpro.2016.03.001
10.1002/jcp.28687
10.1016/j.phrs.2019.104511
10.3322/caac.21551
10.1016/j.bpg.2007.10.007
10.1158/1078-0432.CCR-14-0365
10.1159/000447872
10.3390/cancers11111628
10.1056/NEJM199305203282001
10.1016/j.biopha.2020.109972
10.1053/gast.1997.v113.pm9247480
10.1111/jcmm.14762
10.1200/JCO.2006.08.2644
10.1016/j.cell.2011.07.014
10.1002/1878-0261.12426
10.1007/s10555-015-9551-7
10.1038/75556
10.1158/0008-5472.CAN-19-0039
10.2147/OTT.S207748
10.1038/s41467-019-11019-w
10.1016/j.carj.2019.07.001
10.1158/1078-0432.CCR-18-3310
10.1093/nar/gkp896
10.1038/nature16965
10.1111/jcmm.14846
10.1056/NEJMcp054958
10.15252/embr.201948170
10.1002/1878-0261.12181
ContentType Journal Article
Copyright The Author(s) 2020
The Author(s) 2020.
2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2020
– notice: The Author(s) 2020.
– notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
NPM
3V.
7TM
7TO
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12935-020-01243-6
DatabaseName Springer Nature OA Free Journals
CrossRef
PubMed
ProQuest Central (Corporate)
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni)
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
Oncogenes and Growth Factors Abstracts
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
Nucleic Acids Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database
PubMed

MEDLINE - Academic

Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1475-2867
EndPage 14
ExternalDocumentID oai_doaj_org_article_f0d3a99ed8334aa6b7e44a9ef40c22b6
PMC7288603
32536819
10_1186_s12935_020_01243_6
Genre Journal Article
Review
GrantInformation_xml – fundername: Provinces and Ministries Co-Contribution of Zhejiang, China
  grantid: WKJ-ZJ-2035
– fundername: the Natural Science Foundation of Zhejiang Province
  grantid: LY17H160057
– fundername: Key projects of Wenzhou science and technology bureau
  grantid: ZY2019016
– fundername: National Natural Sciences Foundation of China
  grantid: 81800567
– fundername: ;
  grantid: WKJ-ZJ-2035
– fundername: ;
  grantid: ZY2019016
– fundername: ;
  grantid: 81800567
– fundername: ;
  grantid: LY17H160057
GroupedDBID ---
0R~
29B
2WC
53G
5GY
5VS
6J9
7X7
8FI
8FJ
AAFWJ
AAJSJ
AASML
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACIWK
ACMJI
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
ISR
ITC
KQ8
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PUEGO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
~8M
AAYXX
CITATION
2VQ
4.4
88E
8R4
8R5
AHSBF
ALIPV
C1A
EJD
H13
IPNFZ
LGEZI
LOTEE
M1P
NADUK
NPM
NXXTH
PJZUB
PPXIY
PSQYO
RIG
3V.
7TM
7TO
7XB
8FK
AZQEC
DWQXO
H94
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c641t-b3af377677304578389fe468ffe41c96d9afcbc877e8db0571fa22c8ad3737553
IEDL.DBID 7X7
ISSN 1475-2867
IngestDate Wed Aug 27 01:25:38 EDT 2025
Tue Sep 30 15:41:39 EDT 2025
Fri Sep 05 14:18:10 EDT 2025
Mon Jun 30 05:28:56 EDT 2025
Mon Jul 21 05:15:49 EDT 2025
Wed Oct 01 03:21:12 EDT 2025
Thu Apr 24 22:53:10 EDT 2025
Sat Sep 06 07:29:35 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Pancreatic adenocarcinoma
Competing endogenous RNA network
Time-dependent receiver operating characteristic
Language English
License The Author(s) 2020.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c641t-b3af377677304578389fe468ffe41c96d9afcbc877e8db0571fa22c8ad3737553
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0002-5070-3834
OpenAccessLink https://www.proquest.com/docview/2414889822?pq-origsite=%requestingapplication%
PMID 32536819
PQID 2414889822
PQPubID 42567
PageCount 14
ParticipantIDs doaj_primary_oai_doaj_org_article_f0d3a99ed8334aa6b7e44a9ef40c22b6
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7288603
proquest_miscellaneous_2413999281
proquest_journals_2414889822
pubmed_primary_32536819
crossref_citationtrail_10_1186_s12935_020_01243_6
crossref_primary_10_1186_s12935_020_01243_6
springer_journals_10_1186_s12935_020_01243_6
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-06-11
PublicationDateYYYYMMDD 2020-06-11
PublicationDate_xml – month: 06
  year: 2020
  text: 2020-06-11
  day: 11
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Cancer cell international
PublicationTitleAbbrev Cancer Cell Int
PublicationTitleAlternate Cancer Cell Int
PublicationYear 2020
Publisher BioMed Central
BMC
Publisher_xml – name: BioMed Central
– name: BMC
References M Kanehisa (1243_CR18) 2010; 38
J Duan (1243_CR19) 2016; 127
G Luo (1243_CR21) 2019; 48
SC Credendino (1243_CR23) 2019
DC Whitcomb (1243_CR2) 2006; 354
C Li (1243_CR28) 2019; 11
B Staal (1243_CR9) 2019; 25
J Tang (1243_CR22) 2019; 20
BW Spanier (1243_CR3) 2008; 22
T Deng (1243_CR8) 2016; 39
S Greco (1243_CR14) 2019; 20
J Yang (1243_CR15) 2019
LB Wang (1243_CR29) 2019; 16
D Tang (1243_CR31) 2019; 234
GY Locker (1243_CR7) 2006; 24
H Ding (1243_CR30) 2019; 12
A Mcguire (1243_CR11) 2015; 34
PC Moore (1243_CR32) 2019; 79
L Salmena (1243_CR12) 2011; 146
B He (1243_CR13) 2017; 7
VO Oria (1243_CR26) 2019; 13
SK Natarajan (1243_CR35) 2019; 11
P Bailey (1243_CR25) 2016; 531
AF Abdel-Wahab (1243_CR34) 2019; 150
BF Zhang (1243_CR16) 2019; 24
BM Karlson (1243_CR5) 1997; 113
DP O’brien (1243_CR6) 2015; 21
W Wang (1243_CR24) 2019; 11
MT Taffel (1243_CR20) 2019; 70
Y Zhang (1243_CR10) 2018; 12
GC Shin (1243_CR33) 2019; 10
RL Siegel (1243_CR1) 2019; 69
M Ashburner (1243_CR17) 2000; 25
F Zhu (1243_CR27) 2020; 125
AB Lowenfels (1243_CR4) 1993; 328
32624707 - Cancer Cell Int. 2020 Jul 1;20:282
References_xml – volume: 20
  start-page: 3079
  issue: 12
  year: 2019
  ident: 1243_CR14
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms20123079
– volume: 79
  start-page: 6190
  issue: 24
  year: 2019
  ident: 1243_CR32
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-19-1116
– volume: 11
  start-page: 2610
  issue: 9
  year: 2019
  ident: 1243_CR24
  publication-title: Aging
  doi: 10.18632/aging.101933
– volume: 11
  start-page: 5593
  issue: 15
  year: 2019
  ident: 1243_CR28
  publication-title: Aging
  doi: 10.18632/aging.102140
– volume: 16
  start-page: 6923
  issue: 6
  year: 2019
  ident: 1243_CR29
  publication-title: Math Biosci Eng
  doi: 10.3934/mbe.2019347
– volume: 48
  start-page: 199
  issue: 2
  year: 2019
  ident: 1243_CR21
  publication-title: Pancreas
  doi: 10.1097/MPA.0000000000001230
– volume: 127
  start-page: 239
  year: 2016
  ident: 1243_CR19
  publication-title: Signal Process
  doi: 10.1016/j.sigpro.2016.03.001
– volume: 234
  start-page: 20816
  issue: 11
  year: 2019
  ident: 1243_CR31
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.28687
– volume: 150
  start-page: 104511
  year: 2019
  ident: 1243_CR34
  publication-title: Pharmacol Res
  doi: 10.1016/j.phrs.2019.104511
– volume: 69
  start-page: 7
  issue: 1
  year: 2019
  ident: 1243_CR1
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21551
– volume: 7
  start-page: 1704
  issue: 8
  year: 2017
  ident: 1243_CR13
  publication-title: Am J Cancer Res
– volume: 22
  start-page: 45
  issue: 1
  year: 2008
  ident: 1243_CR3
  publication-title: Best Pract Res Clin Gastroenterol
  doi: 10.1016/j.bpg.2007.10.007
– volume: 21
  start-page: 622
  issue: 3
  year: 2015
  ident: 1243_CR6
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-14-0365
– volume: 39
  start-page: 1716
  issue: 5
  year: 2016
  ident: 1243_CR8
  publication-title: Cell Physiol Biochem
  doi: 10.1159/000447872
– volume: 11
  start-page: 1628
  issue: 11
  year: 2019
  ident: 1243_CR35
  publication-title: Cancers
  doi: 10.3390/cancers11111628
– volume: 328
  start-page: 1433
  issue: 20
  year: 1993
  ident: 1243_CR4
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199305203282001
– volume: 125
  start-page: 109972
  year: 2020
  ident: 1243_CR27
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2020.109972
– volume: 113
  start-page: 587
  issue: 2
  year: 1997
  ident: 1243_CR5
  publication-title: Gastroenterology
  doi: 10.1053/gast.1997.v113.pm9247480
– year: 2019
  ident: 1243_CR15
  publication-title: J Cell Mol Med.
  doi: 10.1111/jcmm.14762
– volume: 24
  start-page: 5313
  issue: 33
  year: 2006
  ident: 1243_CR7
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2006.08.2644
– volume: 146
  start-page: 353
  issue: 3
  year: 2011
  ident: 1243_CR12
  publication-title: Cell
  doi: 10.1016/j.cell.2011.07.014
– volume: 13
  start-page: 456
  issue: 2
  year: 2019
  ident: 1243_CR26
  publication-title: Mol Oncol
  doi: 10.1002/1878-0261.12426
– volume: 34
  start-page: 145
  issue: 1
  year: 2015
  ident: 1243_CR11
  publication-title: Cancer Metastasis Rev
  doi: 10.1007/s10555-015-9551-7
– volume: 25
  start-page: 25
  issue: 1
  year: 2000
  ident: 1243_CR17
  publication-title: Nat Genet
  doi: 10.1038/75556
– year: 2019
  ident: 1243_CR23
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-19-0039
– volume: 12
  start-page: 6733
  year: 2019
  ident: 1243_CR30
  publication-title: Onco Targets Ther
  doi: 10.2147/OTT.S207748
– volume: 10
  start-page: 3185
  issue: 1
  year: 2019
  ident: 1243_CR33
  publication-title: Nat Commun
  doi: 10.1038/s41467-019-11019-w
– volume: 70
  start-page: 416
  issue: 4
  year: 2019
  ident: 1243_CR20
  publication-title: Can Assoc Radiol J
  doi: 10.1016/j.carj.2019.07.001
– volume: 25
  start-page: 2745
  issue: 9
  year: 2019
  ident: 1243_CR9
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-18-3310
– volume: 38
  start-page: D355
  issue: Database issue
  year: 2010
  ident: 1243_CR18
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkp896
– volume: 531
  start-page: 47
  issue: 7592
  year: 2016
  ident: 1243_CR25
  publication-title: Nature
  doi: 10.1038/nature16965
– volume: 24
  start-page: 1099
  issue: 1
  year: 2019
  ident: 1243_CR16
  publication-title: J Cell Mol Med.
  doi: 10.1111/jcmm.14846
– volume: 354
  start-page: 2142
  issue: 20
  year: 2006
  ident: 1243_CR2
  publication-title: N Engl J Med
  doi: 10.1056/NEJMcp054958
– volume: 20
  start-page: e48170
  issue: 12
  year: 2019
  ident: 1243_CR22
  publication-title: EMBO Rep.
  doi: 10.15252/embr.201948170
– volume: 12
  start-page: 1429
  issue: 9
  year: 2018
  ident: 1243_CR10
  publication-title: Mol Oncol
  doi: 10.1002/1878-0261.12181
– reference: 32624707 - Cancer Cell Int. 2020 Jul 1;20:282
SSID ssj0017860
Score 2.3948743
SecondaryResourceType review_article
Snippet Background Emerging evidence suggests that competing endogenous RNAs plays a crucial role in the development and progress of pancreatic adenocarcinoma (PAAD)....
Emerging evidence suggests that competing endogenous RNAs plays a crucial role in the development and progress of pancreatic adenocarcinoma (PAAD). The...
Background Emerging evidence suggests that competing endogenous RNAs plays a crucial role in the development and progress of pancreatic adenocarcinoma (PAAD)....
Abstract Background Emerging evidence suggests that competing endogenous RNAs plays a crucial role in the development and progress of pancreatic adenocarcinoma...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 231
SubjectTerms Accuracy
Adenocarcinoma
Biomedical and Life Sciences
Biomedicine
Cancer Research
Cell Biology
Competing endogenous RNA network
Gene expression
Genes
Genomes
Genotypes
Homeostasis
Hypotheses
Medical prognosis
Metabolism
MicroRNAs
miRNA
mRNA
Non-coding RNA
Pancreas
Pancreatic adenocarcinoma
Pancreatic cancer
Prognosis
Time-dependent receiver operating characteristic
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LaxUxFD5IoeBGfDtaSwR3OnTyzixraSmCXYiF7kImD7yoM9J7XfjvPUlmrl6fGzezmDwI55zkfEnO-QLwPPkgORtoi2A1tCLn5QyGxtZ75gMXPkSVc4ffXKjzS_H6Sl798NRXjgmr9MBVcEepC9z1fQyGc-GcGnQUwvUxic4zNhSybXRjy2Zqvj_QRnVLioxRR-vs1XImcg7CYoK3ascNFbb-30HMXyMlf7ouLV7o7DbcmuEjOa7DvgM34ngX9uuDkl_vwYead5vmgzgyJeKIL9AYuyNxDFMlZSVvL47JWEPAiZtVFAPJx7Ikx2yN03q1zu1xtajA0hOHnaPru_arcfrk7sPl2em7k_N2fk6h9UrQTTtwl3gm79H5dlQbhCopCmUSfqnvVehd8oM3WkcTBsRxNDnGvHGBa66l5A9gb5zG-AhI5zyPQZpe9p2IkTkenWTBe0k1rhmiAbpI1_qZazw_efHRlj2HUbZqxKJGbNGIVQ282Lb5XJk2_lr7VVbatmZmyS4_0HbsbDv2X7bTwMGicjtP3bVFSIOLWqY1bODZthgnXb5JcWNEHeU6COx6ZmgDD6uFbEfCmeQKcVYDesd2doa6WzKu3hdib80M2i1v4OViZd-H9WdRPP4fongCN1mZHqql9AD2Ntdf4lOEW5vhsMysb8PHKDQ
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZKERIXxJtAQUZCXCAQP2I7B4QKoqqQ2gNipd4sxw9YUZJ2d5Hov2fGSbZaWHrZw8axHM83ni-ZFyEvkg-14C0rgayGUmJeTmtYLL3nPgjpQ1SYO3x0rA5n8vNJfbJDpnDbcQOXW1_tsJ_UbHH65vf5xXtQ-HdZ4Y16u0SbhXnGGGLFpSjVy7PzEhtLoQN27LJxjVwHY8UR-Efy0tGgjaqmXJqtU23Yq1zWfxsX_Tek8i-_ajZXB7fJrZFn0v0BGHfITuzukhtD58mLe-THkKCbxi92tE_UUZ85NExHYxf6oXor_XK8T7shVpy6UZYxUPx-SzG4q-uX8yXeD8fKwEA9dTA52MiFn3f9T3efzA4-ff14WI59F0qvJFuVrXBJYJUfjW5UbYDTpCiVSfDLfKNC45JvvdE6mtAC4WPJce6NC0ILXdfiAdnt-i4-IrRyXsRQm6ZuKhkjdyK6mgfva6bhcJEFYdPuWj8WJcfeGKc2v5wYZQeJWJCIzRKxqiCv1vecDSU5rhz9AYW2HonltPMf_eKbHbXTpioI1zQxGCGkc6rVUUrXxCQrz3kLk-xNIrcTRC3ACU4_rH9YkOfry6Cd6HJxXQQZ4RhggA03rCAPB4SsVyJ4LRQQsoLoDexsLHXzSjf_niuAa24At6IgryeUXS7r_1vx-OqneEJu8gx8VTK2R3ZXi1_xKTCuVfss68wf6RApkw
  priority: 102
  providerName: Scholars Portal
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3Ni9UwEA-6IngRv62uEsGbFpvv9Lg-XBbBPYgLewtpPvChprLvefC_d6bpqz5dBS89tJMQMjPJr5mZXwh5nkNUgg-sBbAaW4l1OYNlqQ2BhyhkiElj7fC7U31yJt-eq_OZJgdrYX6N3zOrX21wP8IaYkyf4lK0-iq5pmDhxfS9lV4tEQNjdbcrirm03d7GM_HzXwYq_8yN_C1AOu07x7fIzRkw0qOq4dvkSip3yPV6heT3u-RTrbTN89EbHTP1NExgGLqjqcSx0rDS96dHtNSkb-pnpaRI8SCWYpZWGTfrDbaH9aFCyUA9dA6b3UVYl_GLv0fOjt98WJ208wUKbdCSbdtB-CyQrsdgPNRYACc5SW0zPFnodex9DkOwxiQbB0BuLHvOg_VRGGGUEvfJQRlLekho54NIUdle9Z1MiXuRvOIxBMUMrBKyIWw3uy7M7OJ4ycVnN_1lWO2qRhxoxE0acbohL5Y2Xyu3xj-lX6PSFknkxZ5egLm42c1c7qLwfZ-iFUJ6rweTpPR9yrILnA_QyeFO5W521o0DEAPLGBIZNuTZ8hncDGMnviTQEcoAlOu5ZQ15UC1kGYngSmhAVg0xe7azN9T9L2X9caLyNtyC3YqGvNxZ2c9h_X0qHv2f-GNyg0-OoFvGDsnB9uJbegJQajs8nXzoB-0UF6U
  priority: 102
  providerName: Springer Nature
Title Identification of a competing endogenous RNA network associated with prognosis of pancreatic adenocarcinoma
URI https://link.springer.com/article/10.1186/s12935-020-01243-6
https://www.ncbi.nlm.nih.gov/pubmed/32536819
https://www.proquest.com/docview/2414889822
https://www.proquest.com/docview/2413999281
https://pubmed.ncbi.nlm.nih.gov/PMC7288603
https://doaj.org/article/f0d3a99ed8334aa6b7e44a9ef40c22b6
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVADU
  databaseName: BioMed Central Open Access Free
  customDbUrl:
  eissn: 1475-2867
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017860
  issn: 1475-2867
  databaseCode: RBZ
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://www.biomedcentral.com/search/
  providerName: BioMedCentral
– providerCode: PRVAFT
  databaseName: Colorado Digital library
  customDbUrl:
  eissn: 1475-2867
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017860
  issn: 1475-2867
  databaseCode: KQ8
  dateStart: 20011101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAFT
  databaseName: Colorado Digital library
  customDbUrl:
  eissn: 1475-2867
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017860
  issn: 1475-2867
  databaseCode: KQ8
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1475-2867
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017860
  issn: 1475-2867
  databaseCode: DOA
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVEBS
  databaseName: EBSCOhost Academic Search Ultimate
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 1475-2867
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017860
  issn: 1475-2867
  databaseCode: ABDBF
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1475-2867
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017860
  issn: 1475-2867
  databaseCode: DIK
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1475-2867
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017860
  issn: 1475-2867
  databaseCode: GX1
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1475-2867
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017860
  issn: 1475-2867
  databaseCode: M~E
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVAQN
  databaseName: PubMed Central (Free e-resource, activated by CARLI)
  customDbUrl:
  eissn: 1475-2867
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017860
  issn: 1475-2867
  databaseCode: RPM
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1475-2867
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017860
  issn: 1475-2867
  databaseCode: 7X7
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1475-2867
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017860
  issn: 1475-2867
  databaseCode: BENPR
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 1475-2867
  dateEnd: 20250131
  omitProxy: true
  ssIdentifier: ssj0017860
  issn: 1475-2867
  databaseCode: M48
  dateStart: 20011101
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
– providerCode: PRVAVX
  databaseName: Springer Nature HAS Fully OA
  customDbUrl:
  eissn: 1475-2867
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017860
  issn: 1475-2867
  databaseCode: AAJSJ
  dateStart: 20011201
  isFulltext: true
  titleUrlDefault: https://www.springernature.com
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: Springer Nature OA Free Journals
  customDbUrl:
  eissn: 1475-2867
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017860
  issn: 1475-2867
  databaseCode: C6C
  dateStart: 20011201
  isFulltext: true
  titleUrlDefault: http://www.springeropen.com/
  providerName: Springer Nature
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bi9QwFA66i-CLeLe6DhF807LNpUn6JDvDLouwgwwuDL6ENEl1UNt1Oj747z1J0y7jZV8CbdKQ5pzkfDk5F4ReN9aVjNYkB7Dqch78cmpFfG4ttY5x67wIvsMXS3F-yd-vy3VSuPXJrHLcE-NG7TobdOTHIGmA10K0uXdXP_KQNSrcrqYUGrfRIQGoErharqcDF5FKFKOjjBLHfZBtwR85mGJRznKxJ4xizP5_Ac2_7SX_uDSNsujsPrqXQCQ-Gaj-AN3y7UN0Z0gr-esR-jp43zZJHYe7BhtsI0CG7rBvXTeEZsWr5QluB0NwbBKhvMNBOYuD5Vbb9Zs-fA97xgAvLTbQOQjArd203XfzGF2enX5cnOcpqUJuBSe7vGamYSGEjwx3pFIBYGk8F6qBkthKuMo0trZKSq9cDWiONIZSq4xjksmyZE_QQdu1_hnChbHMu1JVZVVw76lh3pTUWVsSCTsHzxAZZ1fbFHE8JL74puPJQwk9UEQDRXSkiBYZejN9czXE27ix9TwQbWoZYmXHF932s05LTzeFY6aqvFOMcWNELT3npvINLyylNXRyNJJcpwXc62t2y9CrqRqWXrhPMa0HGoU2AO8qqkiGng4cMo2E0ZIJQFsZknu8szfU_Zp28yWG95ZUAd-yDL0duex6WP-fiuc3_8ULdJdGxhc5IUfoYLf96V8CnNrVs7hmZuhwfrr8sIKnhVjMomoCyguuoFzNP_0Ghw0kQA
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jb9QwFLaqIgQXxE6ggJHgBFHjJbZzQKgs1ZS2c0CtNDfj2A6MgKRMBqH-KX4j72WZalh66yWHxLYcv-8ttt9CyNPKh1zwkqVgrIZUYlxOaVhMvec-COlDVBg7fDhVk2P5fpbPNsivMRYG3SpHmdgJ6tB4PCPfBk0DWMNsc69OvqdYNQpvV8cSGj0s9uPpT9iytS_33gJ9n3G---7ozSQdqgqkXkm2TEvhKoE5bDReEmoDGruKUpkKnswXKhSu8qU3WkcTSjBnWOU498YFoYXOsUoEiPxLEnpjrn49W23wmDYqGwNzjNpuUZdi_DO6fnEpUrWm_LoaAf8ybP_2z_zjkrbTfbvXybXBaKU7PcpukI1Y3ySX-zKWp7fIlz7atxqO_2hTUUd9Z5DDcDTWoelTwdIP0x1a947n1A3AiIHiYTBFT7G6aect9gcZ1ZuznjoYHBTuws_r5pu7TY4vZLnvkM26qeM9QjPnRQy5KfIikzFyJ6LLefA-ZxoklUwIG1fX-iHDORba-Gq7nY5RtqeIBYrYjiJWJeT5qs9Jn9_j3NavkWirlpibu3vRLD7ZgdVtlQXhiiIGI4R0TpU6SumKWMnMc17CIFsjye0gMFp7Bu-EPFl9BlbH-xtXR6ARtgFzsuCGJeRuj5DVTATPhQLrLiF6DTtrU13_Us8_d-nENTeAW5GQFyPKzqb1_6W4f_5fPCZXJkeHB_Zgb7r_gFzlHROolLEtsrlc_IgPwZRblo86_qHk40Uz7G_BlVuB
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LjxQhECa6G40X49vWVTHxpp1tHg30cXxM1lEnRt1kb4TmoROV3syMB_-9RdPdOrqaeOlDUxBCUfBBVX0g9ChYVzPakhLAqit5ystpFfGltdQ6xq3zIuUOv1mKo2O-OKlPfsni76PdR5dkzmlILE1xe3jqQjZxJQ43aZdKmcUpqIpyVorzaF_VjYDj1_5stni_mDwJUolqTJY5s-bOhtTz9p8FNv-MmfzNcdrvR_Mr6PIAJPEsa_4qOufjNXQhPy35_Tr6nDNww3Alh7uADbY9SIbmsI-uy_Ss-N1yhmMOBsdmUJZ3OF3Q4hS9FbvNapPqw7qRIabFBhqHTXBtV7H7am6g4_mLD8-OyuFhhdIKTrZly0xgicZHJj-pVABagudCBfgS2wjXmGBbq6T0yrWA6EgwlFplHJNM1jW7ifZiF_1thCtjmXe1auqm4t5Tw7ypqbO2JhJWD14gMo6utgPreHr84ovuTx9K6KwRDRrRvUa0KNDjqc5p5tz4p_TTpLRJMvFl9z-69Uc9mJ8OlWOmabxTjHFjRCs956bxgVeW0hYaORhVrgcj3mgAN7C8JYLDAj2cisH8kk_FRA86SjIA8RqqSIFu5Rky9YTRmglAXAWSO3Nnp6u7JXH1qaf4llTBvGUFejLOsp_d-vtQ3Pk_8Qfo4tvnc_365fLVXXSJ9jYhSkIO0N52_c3fA7S1be8PBvUDNUUkUA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identification+of+a+competing+endogenous+RNA+network+associated+with+prognosis+of+pancreatic+adenocarcinoma&rft.jtitle=Cancer+cell+international&rft.au=Weng%2C+Wanqing&rft.au=Zhang%2C+Zhongjing&rft.au=Huang%2C+Weiguo&rft.au=Xu%2C+Xiangxiang&rft.date=2020-06-11&rft.pub=BioMed+Central&rft.eissn=1475-2867&rft.volume=20&rft.spage=1&rft_id=info:doi/10.1186%2Fs12935-020-01243-6
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1475-2867&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1475-2867&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1475-2867&client=summon